BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Thermo Fisher Secures FDA Approval for Oncomine Dx Express Test as Companion Diagnostic for Dizal’s ZEGFROVY

Thermo Fisher Scientific, the world leader in serving science, announced the U.S. Food and Drug Administration (FDA) has approved the Oncomine&t...

July 04, 2025 | News

Sartorius Finalises Acquisition of MatTek and Visikol to Bolster Cell Technology Portfolio

The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO ...

July 03, 2025 | News

XtalPi Expands AI-Driven Drug Discovery Collaboration with Pfizer to Develop Next-Generation Molecular Modeling Platform

XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking m...

June 30, 2025 | News

Vetter Breaks Ground on New Clinical Manufacturing Site in Illinois to Expand U.S. Operations

Production site expected to be fully operational by the end of 2029 Modern site with holistic approach for state-of-the-art manufacturing operations Fu...

June 30, 2025 | News

LTS and Nualtis Forge Strategic Alliance to Scale Oral Thin Film Drug Manufacturing Globally

LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film ...

June 26, 2025 | News

Xcell Biosciences and Thermo Fisher Scientific Unite to Advance Treg and TIL Cell Therapies for Autoimmune and Solid Tumor Diseases

Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic coll...

June 25, 2025 | News

Formation Bio Licenses Gusacitinib to Sanofi in Deal Worth Up to €545 Million

Deal could be worth up to €545 million, including upfront and milestone payments, as well as low to mid-teen royalties based on ...

June 24, 2025 | News

Daiichi Sankyo and AstraZeneca’s DATROWAY Receives U.S. FDA Accelerated Approval for EGFR-Mutated Lung Cancer

Based on TROPION-Lung05 phase 2 trial results and supported by data from the TROPION-Lung01 phase 3 trial Second U.S. approval for Daiichi Sankyo and ...

June 24, 2025 | News

Illumina to Acquire SomaLogic for $350 Million, Expanding Proteomics Portfolio and Advancing Multiomics Vision

Combines highly complementary proteomics expertise with Illumina’s industry-leading product innovation and global market reach Positions Illumina to...

June 24, 2025 | News

Harbour BioMed and Otsuka Ink $670M+ Global Deal to Advance Bispecific T-Cell Engager for Autoimmune Diseases

Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology,&nb...

June 23, 2025 | News

XtalPi and DoveTree Sign $100M+ LOI to Accelerate AI-Driven Drug Discovery Across Oncology and Neurology

XtalPi, a global leader in AI- and robotics-powered drug and materials discovery, announced it has signed a Letter of Intent (LOI) with DoveTre...

June 23, 2025 | News

Veranova Invests Over $50M to Launch Bioconjugation Development and GMP Manufacturing in Massachusetts

Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pha...

June 19, 2025 | News

Waters Launches Alliance iS HPLC Software 2.0, Setting New Industry Standard for Data Security and Traceability

Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security. Integration of Alliance...

June 18, 2025 | News

Abu Dhabi Department of Health and Boehringer Ingelheim Forge Strategic Partnership to Advance Life Sciences and Innovation at BIO 2025

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU)...

June 17, 2025 | News

Stay Connected